Dissolution test for solid oral dosage forms.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 80
- Publication type:
- Article
Works matching IS 10109609 AND DT 2018 AND VI 32 AND IP 1
Results: 69
1
2
Amoxicillin and clavulanic acid tablets (Amoxicillini et acidi clavulanici compressi).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 76
- Publication type:
- Article
3
Clavulanate potassium (Kalii clavulanas).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 67
- Publication type:
- Article
4
Amoxicillin trihydrate (Amoxicillinum trihydricum).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 60
- Publication type:
- Article
5
Clindamycin palmitate powder for oral solution (Clindamycini palmitas pulvis pro solutione perorali).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 57
- Publication type:
- Article
6
Clindamycin palmitate hydrochloride (Clindamycini palmitas hydrochloridum).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 53
- Publication type:
- Article
7
Moxifloxacin tablets (Moxifloxacini compressi).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 50
- Publication type:
- Article
8
Moxifloxacin hydrochloride (Moxifloxacini hydrochloridum).
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 44
- Publication type:
- Article
9
18<sup>th</sup> ICDRA.
- Published in:
- 2018
- Publication type:
- Proceeding
10
First typhoid conjugate vaccine prequalified.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 42
- Publication type:
- Article
11
Lassa fever: Largest-ever outbreak in Nigeria.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 42
- Publication type:
- Article
12
Cholera: WHO responds to outbreaks.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 41
- Publication type:
- Article
13
Non-communicable diseases: New high level commission.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 41
- Publication type:
- Article
14
Poliovirus: High stakes in eradication endgame.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 41
- Publication type:
- Article
15
Tracking industry action on AMR.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 40
- Publication type:
- Article
16
Antibiotic use in England.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 40
- Publication type:
- Article
17
High resistance levels worldwide.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 39
- Publication type:
- Article
18
CIOMS Guide to vaccine safety communication.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 39
- Publication type:
- Article
19
Children's medicines in the DRC.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 38
- Publication type:
- Article
20
Benzathine penicillin G shortages.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 38
- Publication type:
- Article
21
Cost prices of essential medicines.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 38
- Publication type:
- Article
22
Pricing of innovative medicines.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 37
- Publication type:
- Article
23
Tracking universal health coverage.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 37
- Publication type:
- Article
24
Extensions of indications.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 36
- Publication type:
- Article
25
Labelling change.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 36
- Publication type:
- Article
26
Biosimilars.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 35
- Publication type:
- Article
27
Approved.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 32
- Publication type:
- Article
28
Under discussion.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 31
- Publication type:
- Article
29
First EMA report on actions for more ethical animal use.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 30
- Publication type:
- Article
30
U.S. and EU to re-focus inspection resources.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 30
- Publication type:
- Article
31
Australia: No suffixes for biosimilar names.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 29
- Publication type:
- Article
32
Switzerland: Additional biological comparators allowed.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 29
- Publication type:
- Article
33
U.S.: Priority reviews for medicines needed by armed forces.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 29
- Publication type:
- Article
34
U.S.: Clinical data summary pilot.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 28
- Publication type:
- Article
35
Orphan medicines approvals.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 28
- Publication type:
- Article
36
Falsified "Augmentin" circulating in Cameroon.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 27
- Publication type:
- Article
37
Falsified cefixime products circulating in the Democratic Republic of the Congo.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 27
- Publication type:
- Article
38
Radium-223 dichloride: Must not be used with abiraterone and prednisone / prednisolone.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 24
- Publication type:
- Article
39
Svizera Labs Pvt Ltd: Notice of Concern withdrawn.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 26
- Publication type:
- Article
40
Combination treatments for asthma: Warning removed.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 25
- Publication type:
- Article
41
Mycophenolate: Updated recommendations for contraception.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 25
- Publication type:
- Article
42
Direct-acting antivirals: Effect on blood glucose not confirmed.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 25
- Publication type:
- Article
43
Qinhuangdao Zizhu Pharmaceutical Co Ltd: Corrective action under way.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 26
- Publication type:
- Article
44
Recombinant live-attenuated dengue vaccine.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 24
- Publication type:
- Article
45
Ulipristal: No new treatment courses to be started.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 24
- Publication type:
- Article
46
Gadolinium-based contrast agents.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 23
- Publication type:
- Article
47
Idarucizumab: Second dose may be needed.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 23
- Publication type:
- Article
48
Opioid cough and cold medicines: Labelling changes.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 23
- Publication type:
- Article
49
Valproate: Updated measures to avoid use in pregnancy.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 23
- Publication type:
- Article
50
Nintedanib: Liver injury.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 22
- Publication type:
- Article